Leslie Cope
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Molecular Biology top 0.5%
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Gene expression and cancer classification
- Bioinformatics and Genomic Networks
- Genomics and Chromatin Dynamics
- Cancer-related gene regulation
Papers in
-
- Cancer Genomics and Diagnostics 30
-
- Ovarian cancer diagnosis and treatment 10
- Co-authors
- Rafael A. IrizarryLaurent GautierBenjamin M. BolstadStephen B. BaylinJames G. HermanKornel E. SchuebelWayne YuGiovanni Parmigiani
- Journals
- Cancer Research (15 papers)PLoS ONE (8 papers)Blood (7 papers)Clinical Cancer Research (4 papers)Journal of Clinical Oncology (4 papers)
- Partner nations
- United StatesBelgiumRussia
In The Last Decade
Leslie Cope
129 papers receiving 10.2k citations
Hit Papers
Peers
Comparison fields: 5 of 157
- Cancer Research 2.4k
- Molecular Biology 6.7k
- Reproductive Medicine 694
- Oncology 1.9k
- Immunology 1.0k
Countries citing papers authored by Leslie Cope
This map shows the geographic impact of Leslie Cope's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie Cope with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie Cope more than expected).
Fields of papers citing papers by Leslie Cope
This network shows the impact of papers produced by Leslie Cope. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie Cope. The network helps show where Leslie Cope may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Leslie Cope, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 12 | |
| 5 | 2020 | 21 | |
| 6 | 2019 | 22 | |
| 7 | 2018 | 99 | |
| 8 | 2018 | 42 | |
| 9 | 2016 | 30 | |
| 10 | 2016 | 133 | |
| 11 | 2014 | 45 | |
| 12 | 2014 | 35 | |
| 13 | 2014 | 118 | |
| 14 | 2013 | 76 | |
| 15 | 2011 | 159 | |
| 16 | 2010 | 23 | |
| 17 | 2008 | 94 | |
| 18 | 2008 | 162 | |
| 19 | 2008 | 41 | |
| 20 | 2006 | 26 |
About Leslie Cope
Leslie Cope is a scholar working on Cancer Research, Reproductive Medicine, Molecular Biology, Oncology and Pathology and Forensic Medicine, having authored 132 papers that have together received 10.3k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (40 papers), Cancer Genomics and Diagnostics (30 papers), Gene expression and cancer classification (19 papers), Genomics and Chromatin Dynamics (14 papers), Bioinformatics and Genomic Networks (11 papers), Ovarian cancer diagnosis and treatment (10 papers), Cancer-related gene regulation (10 papers) and Pancreatic and Hepatic Oncology Research (9 papers). The work is most often cited by research in Cancer Research (2.4k citations), Molecular Biology (6.7k citations), Reproductive Medicine (694 citations), Oncology (1.9k citations) and Immunology (1.0k citations). Leslie Cope has collaborated with scholars based in United States, Belgium and Russia. Frequent co-authors include Rafael A. Irizarry, Laurent Gautier, Benjamin M. Bolstad, Stephen B. Baylin, James G. Herman, Kornel E. Schuebel, Wayne Yu, Giovanni Parmigiani, Robert J. Kurman and Ie‐Ming Shih. Their work appears in journals such as Cancer Research, PLoS ONE, Blood, Clinical Cancer Research and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.